The fungal meningitis outbreak is bringing the work of compounding pharmacies into the public eye, and many people do not like what they see.
Compounding pharmacies prepare medications that that are not readily available from a true drug manufacturer. The number of such facilities have exploded in the last decade and now some 2000 of these pharmacies exist. Most of them produce a relatively small number of products, but some of them, like the New England Compounding Center (NECC) that compounded the steroid used for epidural injections that gave risk to the outbreak, are quite large.
The Wall Street Journal has an article in today’s paper about how some doctors are thinking the use of such pharmacies.